Dr. Brian McHugh is a board-certified neurosurgeon practicing in the New York City metro region, where he specializes in treating complex spinal conditions and degenerative diseases. Having completed his residency at Yale University and a specialized fellowship at the Hospital for Special Surgery, he brings a highly technical and patient-centered perspective to the evolving landscape of surgical preparation. This interview explores the profound impact that the rise of medical weight loss is having on the operating room, particularly as national spending on GLP-1 medications has surged from $13.7 billion to $71.7 billion in just five years. We examine how these pharmaceutical advancements are shifting the clinical conversation from one of personal failure to one of metabolic optimization, the tangible link between modest weight loss and reduced surgical complications, and why the instinct to move “sooner” in elective surgery is often at odds with the physiological reality of the patient’s recovery.
GLP-1 medication spending has increased over fivefold in recent years, signaling a major shift in patient health. How have you personally witnessed this transition within your practice when patients come in for a neurosurgical consultation?
In just the last few years, the landscape of who shows up in my clinic has changed fundamentally, moving away from a time when weight loss was a struggle defined almost entirely by diet and exercise. We have seen national spending on GLP-1 medications jump from $13.7 billion to over $71.7 billion, and that massive growth is reflected in the faces of the people I see every day. I no longer just see patients in the early stages of a weight-related health crisis; I see people who are already actively engaged in medical weight loss or who have already achieved measurable metabolic improvement. Five years ago, it was rare to have a patient arrive for a spine consultation having already lost twenty or thirty pounds through a medically supervised program. Now, it is becoming a common part of the preoperative history, which completely changes the baseline of our surgical planning. This shift is more than just a trend—it is a structural change in how we prepare the human body for the rigors of the operating room.
From your perspective as a surgeon, how does a high BMI transition from being a simple number on a chart to a complex physiological variable that affects the outcome of a procedure?
Obesity is never just a number in my office; it is a critical variable that dictates how I handle a patient’s tissue, how they respond to anesthesia, and how they heal after I have finished the final stitch. Data from a multicenter analysis in Cureus reinforces what we see at the bedside: patients with obesity face significantly higher rates of surgical site infections and pulmonary complications compared to those at a normal weight. During spine surgery specifically, excess weight makes patient positioning more difficult, increases the risk of blood loss, and places immense strain on the wound during the critical healing phase. These are not just theoretical risks; they lead to longer operative times and extended hospital stays that tax the patient’s physical and emotional reserves. When we look at the broader metabolic picture, including sleep apnea or cardiovascular strain, we realize that a high BMI is often just the visible marker for a body that is already operating under significant physiological stress.
There is a common misconception that weight loss must be dramatic to be effective. Could you explain the significance of the “five percent factor” and how it influences both clinical safety and healthcare costs?
We often see a misconception where patients feel that if they don’t achieve a total transformation, their efforts aren’t worth the trouble, but the data suggests otherwise. Even a modest 5 percent reduction in BMI can be a turning point for surgical safety, as it often correlates with better blood pressure control and stabilized glucose levels. In terms of the economic burden, a 5 percent reduction has been linked to projected health care savings of roughly 7 to 8 percent, a trend seen in both Medicare and employer-sponsored insurance data. Physiologically, that small percentage can mean the difference between a wound that heals cleanly and one that develops a complication requiring a second procedure. It isn’t about aesthetics; it is about widening the margin of safety so that the patient’s recovery is as predictable as possible. When a patient arrives 5 to 10 percent lighter, they aren’t just smaller—they are metabolically more resilient.
While weight loss is often viewed as a positive, there are growing concerns about the loss of lean mass and high discontinuation rates. How do you balance the benefits of medical weight loss with the risks of muscle preservation and frailty?
The goal of preoperative preparation is metabolic optimization, not just weight reduction at any cost, because losing the wrong kind of weight can be just as dangerous as the weight itself. Recent reporting, including insights from The New York Times, has highlighted high discontinuation rates for GLP-1s due to side effects or cost, as well as the risk of losing muscle mass, which is a major concern for older surgical candidates. If a patient loses significant lean mass, they face a higher risk of frailty and postoperative falls, which can completely undo the success of a complex spine surgery. To counter this, I focus on a “muscle-first” mentality, encouraging coordination with primary care or endocrinology to ensure adequate protein intake and resistance training. We have to be responsible about how this weight is lost, ensuring that the patient retains the strength they need to get out of bed and walk the day after their operation.
How has the availability of these new medical tools changed the tone of your conversations with patients who may have felt stigmatized by their weight in the past?
The cultural tone around weight in the medical setting has undergone a necessary and welcome shift toward a more clinical, less defensive dialogue. When a patient comes in having already sought out medical weight loss, we can talk about BMI as a surgical variable—much like we talk about bone density or blood pressure—rather than a personal failure or a character issue. This removes the stigma and allows us to focus on the objective goal: reducing the three-times-higher direct medical costs and the increased risks associated with obesity. The conversation becomes practical and honest, focusing on how we can align their physiology with the demands of the procedure. It is about safety and protection, and when patients feel that their doctor sees their condition as a disease state to be managed rather than a flaw to be judged, the partnership between surgeon and patient becomes much stronger.
In an era where patients often want immediate relief from pain, how do you explain the “sooner does not always mean safer” philosophy when it comes to elective surgery?
It is entirely understandable that someone in chronic pain wants relief as quickly as possible, and for patients with progressive neurologic deficits, we do move with urgency. However, for elective spine surgery, taking a short window of time to optimize a patient’s health is like training an athlete for a high-stakes game—you wouldn’t send them onto the field without preparation. If we can use that time to achieve even a 5 to 10 percent weight reduction while stabilizing cardiovascular markers, the surgery becomes safer and the recovery becomes much more predictable. We have to remember that surgery is a controlled form of physiological stress, and the outcome depends heavily on the “reserve” the patient has in their system. Delaying for the sake of optimization isn’t about denying care; it’s about making sure that when we do operate, we are giving the patient the best possible chance at a complication-free life.
What is your forecast for how medical weight loss will continue to redefine the standards of preoperative care and surgical economics?
I believe we are entering an era where metabolic “pre-habilitation” will become as standard as a routine blood test before surgery, fundamentally lowering the cumulative cost burden of surgical complications. As we see complication rates decrease due to better patient preparation, we will see a natural decline in readmissions, wound issues, and the need for extended rehabilitation. The financial data already shows that as obesity severity increases, so do the costs, but we now have the tools to reverse that trend before the first incision is even made. My forecast is that the surgical lane will remain focused on the operation itself, but our “border control” will become much stricter, utilizing medical weight management to ensure every patient enters the theater in peak physiological condition. Ultimately, this will lead to a healthcare system that is not just more efficient, but one where the results we achieve in the operating room are more durable and life-changing for the patients we serve.
